Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Quantification of microRNA-210 in the cerebrospinal fluid and serum: Implications for Alzheimer’s disease

14 Jan 2015

Abstract excerpt

The aim of the present study was to investigate the potential clinical application of the genetic marker microRNA (miRNA)-210 in the cerebrospinal fluid (CSF) and serum of patients with Alzheimer's disease (AD). The enrolled patients were divided into the mild cognitive impairment (MCI) and AD groups. Healthy individuals were used as the controls. The mRNA and protein expression of vascular endothelial growth...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to MicroRNA in disease regulation
Share to Neurological Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25667669
DOI: 10.3892/etm.2015.2179

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Quantification of microRNA-210 in the cerebrospinal fluid and serum: Implications for Alzheimer’s diseasePMID 25667669Read ↗

Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer diseaseSemantic proximity Read ↗

microRNA-Based Biomarkers in Alzheimer’s Disease (AD)Semantic proximity Read ↗

miRNAs as Therapeutic Tools in Alzheimer’s DiseaseSemantic proximity Read ↗

MicroRNAs in Alzheimer’s Disease: Function and Potential Applications as Diagnostic BiomarkersSemantic proximity Read ↗

microRNA-150-5p: A Novel Blood-Based Biomarker for Alzheimer’s Dementia with Good Correlation to Cognition, Cerebrospinal Fluid Amyloid-β, and Cerebral AtrophySemantic proximity Read ↗

MicroRNAs in Alzheimer's disease: Potential diagnostic markers and therapeutic targetsSemantic proximity Read ↗

MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s DiseaseSemantic proximity Read ↗

Serum Aberrant Expression of miR-24-3P and Its Diagnostic Value in Alzheimer’s DiseaseSemantic proximity Read ↗

Literature-Identified Serum miRNA Signatures for Cognitive Decline: Integrated Analysis and Machine-Learning Diagnostics in Alzheimer’s DiseaseSemantic proximity Read ↗

Elevated levels of serum miR-155 and miR-30c as Potential Biomarkers for Alzheimer's DiseaseSemantic proximity Read ↗

MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease.Semantic proximity Read ↗

Insights into the Role of microRNAs as Clinical Tools for Diagnosis, Prognosis, and as Therapeutic Targets in Alzheimer’s DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.